Abstract
The physiological pharmacokinetic approach to the modeling of drug distribution is reviewed. These models allow extrapolation outside the range of data with some confidence if the dominant mechanisms of transport are sufficiently well understood. In addition, it is possible to extrapolate to other species. Compartments correspond to anatomical spaces so that biochemical interactions (including drug effect or pharmacodynamics) can be incorporated in the model. The articles summarized in this review are limited to models dealing with drug application.
Similar content being viewed by others
References
T. Teorell. Kinetics of distribution of substances administered to the body.Arch. Intern. Pharmacodyn. 57:205–240 (1937).
J. A. Jacques, R. Bellman, and R. Kabala. Some mathematical aspects of chemotherapy. I. One organ models.Bull. Math. Biophys. 22:309–322 (1960).
R. L. Dedrick and K. B. Bischoff. Pharmacokinetics in applications of the artificial kidney.Chem. Eng. Progr. Symp. Ser. 64:32–44 (1968).
K. B. Bischoff and R. L. Dedrick. Thiopental pharmacokinetics.J. Pharm. Sci. 57:1346–1351 (1968).
R. L. Dedrick, D. D. Forrester, and K. H. W. Ho.In vitro-in vivo correlation of drug metabolism—Deamination of 1-D-arabinofuranosylcytosine.Biochem. Pharmacol. 21:1–16 (1972).
R. L. Dedrick, D. D. Forrester, J. N. Cannon, S. M. El Dareer, and L. B. Mellett. Pharmacokinetics of 1-Β-D-arabinofuranosylcytosine (Ara-C) deamination in several species.Biochem. Pharmacol. 22:2405–2417 (1973).
P. F. Morrison, T. L. Lincoln, and J. Aroesty. Disposition of cytosine arabinoside and its metabolites: A pharmacokinetic simulation.Cancer Treat. Rep. 59:861–876 (1975).
K. J. Himmelstein and J. F. Gross. Mathematical model for cyclocytidine pharmacokinetics.J. Pharm. Sci. 66:1441–1444 (1977).
R. J. Lutz, W. M. Galbraith, R. L. Dedrick, R. Shrager, and L. B. Mellett. A model for the kinetics of distribution of actinomycin-D in the beagle dog.J. Pharmacol. Exp. Ther. 200:469–478 (1977).
L. Tterlikkis, E. Ortega, R. Solomon, and J. L. Day. Pharmacokinetics of mercaptopurine.J. Pharm. Sci. 66:1454–1457 (1977).
K. B. Bischoff, R. L. Dedrick, D. S. Zaharko, and J. A. Longstreth. Methotrexate pharmacokinetics.J. Pharm. Sci. 60:1128–1133 (1971).
B. Montandon, R. J. Roberts, and L. J. Fischer. Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man.J. Pharmacokin. Biopharm. 3:277–299 (1975).
C. N. Chen, D. L. Coleman, J. D. Andrade, and A. R. Temple. Pharmacokinetic model for salicylate in cerebrospinal fluid, blood, organs and tissues.J. Pharm. Sci. 67:38 (1978).
N. Benowitz, R. P. Forsyth, K. C. Melmon, and M. M. Rowland. Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.Clin. Pharmacol. Ther. 16:87–109 (1977).
P. A. Harris and J. F. Gross. Preliminary pharmacokinetic model for adriamycin.Cancer Chemother. Rep. 54:819–825 (1975).
L. I. Harrison and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.J. Pharm. Sci. 66:1138–1142 (1977).
R. L. Dedrick, D. S. Zaharko, and R. J. Lutz. Transport and binding of methotrexate.in vivo. J. Pharm. Sci. 62:882–890 (1973).
R. J. Lutz, R. L. Dedrick, J. A. Straw, M. M. Hart, P. Klubes, and D. S. Zaharko. The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma.J. Pharmacokin. Biopharm. 3:77–97 (1975).
R. L. Dedrick, D. S. Zaharko, R. A. Bender, W. A. Bleyer, and R. J. Lutz. Pharmacokinetic considerations on resistance to anticancer drugs.Cancer Chemother. Rep. 59:795–804 (1975).
R. L. Dedrick, C. E. Myers, P. M. Bungay, and V. T. DeVita. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.Cancer Treat. Rep. 62:1–11 (1978).
K. B. Bischoff, R. L. Dedrick, and D. S. Zaharko. Preliminary model for methotrexate pharmacokinetics.J. Pharm. Sci. 59:149–154 (1970).
R. L. Dedrick and D. D. Forrester. Blood flow limitations in interpreting Michaelis constants for ethanol oxidationin vivo.Biochem. Pharmacol. 22:1133–1140 (1973).
K. B. Bischoff and R. G. Brown. Drug distribution in mammals.Chem. Eng. Progr. Symp. Ser. 62:32–45 (1966).
D. S. Greene, R. Quintiliani, and C. H. Nightinggale. Physiological perfusion model for cephalosporin antibiotics I: Model selection based on blood drug concentrations.J. Pharm. Sci. 67:191–196 (1978).
P. M. Bungay, R. L. Dedrick, and A. M. Guarino. Pharmacokinetic modeling of the dogfish shark: Distribution and urinary and biliary excretion of phenol red and its glucuronide.J. Pharmacokin. Biopharm. 4:377–388 (1976).
R. J. Lutz, R. L. Dedrick, H. B. Matthews, T. E. Eling, and M. W. Anderson. A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat.Drug Metab. Disp. 5:386–396 (1977).
K. J. Himmelstein, I. Guvenir, and T. F. Patton. Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.J. Pharm. Sci. 67:603–606 (1978).
J. A. Longstreth. Simulation of cellular response to methotrexate: Effects of membrane transport, enzyme synthesis, and cytokinetics. InProceedings of the 1976 Summer Computer Simulation Conference, Washington, D.C., July 12–14, AFIPS Press, Montvale, N.J., 1976.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Himmelstein, K.J., Lutz, R.J. A review of the applications of physiologically based pharmacokinetic modeling. Journal of Pharmacokinetics and Biopharmaceutics 7, 127–145 (1979). https://doi.org/10.1007/BF01059734
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059734